MPN News

• Anxiety and depression in Myeloproliferative Neoplasm patients
  Nationwide Population-based survey in Denmark Objective: We sought to determine the prevalence and severity of anxiety and depression among patients with Philadelphia-negative myeloproliferative neoplasms (MPNs) and […] The post Anxiety and depression in Myeloproliferative Neoplasm patients appeared first on MPN Cancer Connection.
• Benefit of Ruxolitinib Treatment in Polycythemia Vera by Dr. Verstovsek
  Dr. Verstovsek on Benefit of Ruxolitinib Treatment in PV Srdan Verstovsek, MD, PhD, director of the Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms at […] The post Benefit of Ruxolitinib Treatment in Polycythemia Vera by Dr. Verstovsek appeared first on MPN Cancer Connection.
• MPN Cancer Connection partners with PAN Foundation on Medication Assistance Programs for MPN Patients
  by David Wallace MPN Cancer Connection is very pleased to announce a new partnership with the PAN Foundation.  Myeloproliferative Neoplasm (MPN) patients may be eligible for […] The post MPN Cancer Connection partners with PAN Foundation on Medication Assistance Programs for MPN Patients appeared first on MPN Cancer Connection.
• Risk of Myeloid Blood Cancers are increased in relatives of patients
    The largest ever study of its type is the first to definitively show an increased risk of blood cancers in relatives of patients. A team […] The post Risk of Myeloid Blood Cancers are increased in relatives of patients appeared first on MPN Cancer Connection.